GSK plc reported purchasing 430,000 of its ordinary shares on February 27, 2026, at prices ranging from 2,153.00p to 2,197.00p per share, as part of its existing buyback program, bringing the total shares purchased since February 17, 2026, to 4,136,000 shares. After this transaction, GSK holds 244,027,094 treasury shares with a total of 4,072,135,394 ordinary shares in circulation.